Michael T. Nally Joins Flagship Pioneering as CEO-Partner

Flagship Pioneering announced Michael T. Nally as CEO-Partner. Michael holds considerable expertise in biopharma which will help him achieve the higher possible value creation for its companies. He will also serve as CEO of Generate Biomedicines, a company focused on pioneering a versatile Generative Biology platform to create a broad array of breakthrough therapeutics.

Flagship Pioneering is an American life sciences venture capital company based in Cambridge, Massachusetts that invests in biotechnology, life sciences, health and sustainability companies. Portfolio companies include the biotechnology company, Moderna. The firm both funds and incubates companies.